These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 18722283)
21. Does sacrificing the deep lobe of parotid gland prevent marginal miss? In regard to Chen et al. (Int J Radiat Oncol Biol Phys 2011;80:1423-1429). Yazici G; Cengiz M; Yildiz F; Ozyigit G Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1321-2; author reply 1322. PubMed ID: 22385719 [No Abstract] [Full Text] [Related]
22. Comparison of CT- and FDG-PET-defined GT: in regard to Paulino et al. (Int J Radiat Oncol Biol Phys 2005;61:1385-1392). Gregoire V; Daisne JF; Geets X Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):308-9; author reply 309. PubMed ID: 16111601 [No Abstract] [Full Text] [Related]
23. The efficacy of FDG-PET in head-and-neck cancer with neck metastasis after definitive radiation treatment: in regard to Yao et al. (Int J Radiat Oncol Biol Phys 2005;63:991-999). Wang TF; Tsai EL; Kao RH Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):633; author reply 633-4. PubMed ID: 16690448 [No Abstract] [Full Text] [Related]
24. In regard to Chen et Al. (Int J Radiat Oncol Biol Phys 2007;69:25-31) and Chao et Al. (Int j Radiat Oncol Biol Phys 2007;69:32-40). Yaeger TE Int J Radiat Oncol Biol Phys; 2008 May; 71(1):317; author reply 317-8. PubMed ID: 18406902 [No Abstract] [Full Text] [Related]
25. When Is a "BED" not a "BED"?-When it is an EQD2: In regard to Buyyounouski et al. (Int J Radiat Oncol Biol Phys 2010;76:1297-1304). Fowler JF; Dale RG Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):640-1. PubMed ID: 20832672 [No Abstract] [Full Text] [Related]
26. Cetuximab-related radiation dermatitis in head-and-neck cancer patients: in regard to Studer et al. (Int J Radiat Oncol Biol Phys in press). Russi EG; Numico G; Merlano MC; Pinto C Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1278; author reply 1278-9. PubMed ID: 21353162 [No Abstract] [Full Text] [Related]
27. Radiosensitivity of human papillomavirus-related tumors: in regard to Gupta et al. (Int J Radiat Oncol Biol Phys 2009;74:928-933). Vozenin-Brotons MC; Deutsch E Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):635; author reply 635-6. PubMed ID: 21195880 [No Abstract] [Full Text] [Related]
28. Linear quadratic modeling of increased late normal-tissue effects in special clinical situations: in regard to Jones et al. (Int J Radiat Oncol Biol Phys 2006;64:948-953). Mandal A Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):631; author reply 631-2. PubMed ID: 16966009 [No Abstract] [Full Text] [Related]
29. In regard to Vordermark et al. (Int J Radiat Oncol Biol Phys 2004;58:1242-1250). Koch CJ Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):1003-4; author reply 1004-5. PubMed ID: 15465220 [No Abstract] [Full Text] [Related]
30. Radiobiological parameters suitable for modeling individual outcomes cannot be obtained by analyzing heterogeneous population data with homogeneous tumor control model: in regard to D'Souza et al. (Int J Radiat Oncol Biol Phys 2004;58:1540-1548). Carlone M; Wilkins D; Raaphorst GP Int J Radiat Oncol Biol Phys; 2005 May; 62(1):298-9. PubMed ID: 15850946 [No Abstract] [Full Text] [Related]
31. What is the clinically relevant relative biologic effectiveness? A warning for fractionated treatments with high linear energy transfer radiation: in regard to Daşu and Toma-DAşu. (Int J Radiat Oncol Biol Phys 2008;70:867-874). Karger CP; Jäkel O; Scholz M; Peschke P; Debus J Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1614; author reply 1614-5. PubMed ID: 18374234 [No Abstract] [Full Text] [Related]
32. Helical tomotherapy as a means of administering total or partial scalp irradiation: In regards to Bedford et al. (Int J Radiat Oncol Biol Phys 2005;62:1549-1558). Khuntia D; Jaradat H; Orton N; Tomé W; Mehta MP; Welsh JS Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1288-9; author reply 1289-90. PubMed ID: 16504768 [No Abstract] [Full Text] [Related]
33. In regards to Barkati et al. (Int J Radiat Oncol Biol Phys 2010;76:410-416). Christiansen H; Rödel RM; Matthias C; Hess CF; Wolff HA Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):639-40. PubMed ID: 20542387 [No Abstract] [Full Text] [Related]
34. Experience with fast neutron radiotherapy at the M.D. Anderson Hospital with emphasis on the randomized head and neck trial. Maor MH; Hussey DH Strahlentherapie Sonderb; 1981; 77():11-6. PubMed ID: 6820983 [No Abstract] [Full Text] [Related]
35. Toward a unified survival curve: in regard to Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852) and Krueger et al. (Int J Radiat Oncol Biol Phys 2007;69:1262-1271). Kavanagh BD; Newman F Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):958-9. PubMed ID: 18514788 [No Abstract] [Full Text] [Related]
36. Re: Cancers of the head and neck region in developing countries. Radiother Oncol. 2003 Apr;67(1):1-2. Gupta T; Laskar SG Radiother Oncol; 2004 Feb; 70(2):207-8; author reply 208-9. PubMed ID: 15028409 [No Abstract] [Full Text] [Related]
37. Cervical neck dissection for complete responders in head-and-neck: a utilitarian ideal? In regard to Thariat et al "Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinoma." (Int J Radiat Oncol Biol Phys 2012;82:e367-e374). Puri A Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):768. PubMed ID: 22633547 [No Abstract] [Full Text] [Related]
38. In regards to Katz et al.: The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva (Int J Radiat Oncol Biol Phys 2003;57:409-418). van der Velden J; Ansink A Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1635; author reply 1635-6. PubMed ID: 15050345 [No Abstract] [Full Text] [Related]
39. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer: in regard to Chen et al. (Int J Radiat Oncol Biol Phys. 2010 Jul 23). Salem A; Al-Rashdan A; Abu-Hijle F; Khader J; Hashem S; Almousa A Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):640; author reply 640. PubMed ID: 21549253 [No Abstract] [Full Text] [Related]
40. Brachytherapy doses for prostate cancer customized to risk factors: is it more important "how much" or "where"? In regard to Stone et al. (Int J Radiat Oncol Biol Phys 2007;69:1472-1477). Oton CA; Oton F Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):962; author reply 962-3. PubMed ID: 18514795 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]